178 related articles for article (PubMed ID: 9306342)
1. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.
Samuelsson O; Mulec H; Knight-Gibson C; Attman PO; Kron B; Larsson R; Weiss L; Wedel H; Alaupovic P
Nephrol Dial Transplant; 1997 Sep; 12(9):1908-15. PubMed ID: 9306342
[TBL] [Abstract][Full Text] [Related]
2. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.
Samuelsson O; Attman PO; Knight-Gibson C; Larsson R; Mulec H; Weiss L; Alaupovic P
J Am Soc Nephrol; 1998 Aug; 9(8):1482-8. PubMed ID: 9697671
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency.
Samuelsson O; Aurell M; Knight-Gibson C; Alaupovic P; Attman PO
Nephron; 1993; 63(3):279-85. PubMed ID: 8446264
[TBL] [Abstract][Full Text] [Related]
4. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
[TBL] [Abstract][Full Text] [Related]
5. The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression.
Samuelsson O; Lee DM; Attman PO; Knight-Gibson C; Mullen JK; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephron; 1999; 82(4):306-11. PubMed ID: 10450032
[TBL] [Abstract][Full Text] [Related]
6. The compositional abnormalities of lipoproteins in diabetic renal failure.
Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
Nephrol Dial Transplant; 1998 Nov; 13(11):2833-41. PubMed ID: 9829487
[TBL] [Abstract][Full Text] [Related]
7. Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.
Rahman M; Yang W; Akkina S; Alper A; Anderson AH; Appel LJ; He J; Raj DS; Schelling J; Strauss L; Teal V; Rader DJ;
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1190-8. PubMed ID: 24832097
[TBL] [Abstract][Full Text] [Related]
8. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
[TBL] [Abstract][Full Text] [Related]
9. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
Attman PO; Alaupovic P
Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
[TBL] [Abstract][Full Text] [Related]
10. Lipoproteins and apolipoproteins during the progression of chronic renal disease.
Grützmacher P; März W; Peschke B; Gross W; Schoeppe W
Nephron; 1988; 50(2):103-11. PubMed ID: 3221949
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure.
Samuelsson O; Attman PO; Knight-Gibson C; Larsson R; Mulec H; Wedel H; Weiss L; Alaupovic P
Nephrol Dial Transplant; 1996 Nov; 11(11):2237-43. PubMed ID: 8941584
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency.
Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephrol Dial Transplant; 1994; 9(11):1580-5. PubMed ID: 7870346
[TBL] [Abstract][Full Text] [Related]
13. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
Samuelsson O; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Alaupovic P
Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.
Boes E; Fliser D; Ritz E; König P; Lhotta K; Mann JF; Müller GA; Neyer U; Riegel W; Riegler P; Kronenberg F
J Am Soc Nephrol; 2006 Feb; 17(2):528-36. PubMed ID: 16382017
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein metabolism and renal failure.
Attman PO; Samuelsson O; Alaupovic P
Am J Kidney Dis; 1993 Jun; 21(6):573-92. PubMed ID: 8503411
[TBL] [Abstract][Full Text] [Related]
16. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
Attman PO; Samuelsson O; Alaupovic P
Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
[TBL] [Abstract][Full Text] [Related]
17. Dyslipoproteinemia in diabetic renal failure.
Attman PO; Nyberg G; William-Olsson T; Knight-Gibson C; Alaupovic P
Kidney Int; 1992 Dec; 42(6):1381-9. PubMed ID: 1474769
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum lipid abnormalities in chronic nephritis.
Hirano H; Yamada Y; Otani H; Kodama N; Mune M; Yukawa S
Kidney Int Suppl; 1999 Jul; 71():S147-9. PubMed ID: 10412761
[TBL] [Abstract][Full Text] [Related]
19. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC
Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
[TBL] [Abstract][Full Text] [Related]
20. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
